The CRISPR technology-based experimental gene editing medication EDIT-101, created by Editas Medicine, was tested for safety and efficacy in the BRILLIANCE study
Explore the frontiers of Biotechnology, Pharma industry and Science with BiotechReality.com. We publish news, reports, and articles. We are exclusively publishing fellowship and studentship updates to light up the way for graduates to find a suitable research position in academia or industry.
The CRISPR technology-based experimental gene editing medication EDIT-101, created by Editas Medicine, was tested for safety and efficacy in the BRILLIANCE study
BiotechReality.com
Contents in the website is licensed under CC BY-NC 4.0
Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary.